Investors

Home » investors » Corporate Information » Corporate Profile

Corporate Profile



Investor Tools

  • Email page
  • PDF view
  • Print view
  • Email Alert
  • RSS Feeds
  • Mobile IR Site
  • Social Media Sharing
  • Email page
  • PDF view
  • Print view
  • Email Alert
  • RSS Feeds
  • Mobile IR Site
  • Social Media Sharing

Stock Quote

  • NASDAQFBIO
  • Market Value ($M)137.84
  • Change ($)0.01
  • Change (%)0.49
  • Volume44,350
  • Stock Quote ($)2.96
As of May 27, 2015 11:16 AM - Minimum 20 minute delay.

Fortress Biotech, Inc. (“Fortress” or “the Company”) is a biopharmaceutical company dedicated to acquiring, developing and commercializing novel pharmaceutical and biotechnology products. Fortress plans to develop and commercialize products that it acquires both directly as well as indirectly by establishing subsidiary companies, also known as Fortress Companies. The Company will leverage its biopharmaceutical business expertise and drug development capabilities to help the Fortress Companies achieve their goals. Additionally, the Company will provide funding and management services to each of the Fortress Companies and from time to time the Company and the Fortress Companies will seek licensing, partnerships, joint ventures, and/or public and private financings to accelerate and provide additional funding to support their research and development programs.

Contact Information

Fortress Biotech, Inc.
3 Columbus Circle
15th Floor
New York, NY 10019
info@fortressbiotech.com

Investor Relations
Lucy Lu, M.D., EVP & CFO
ir@fortressbiotech.com
(781) 652-4525



All Releases